Dyne Therapeutics GAAP EPS of -$0.73 beats by $0.04
Source: SeekingAlpha
2026-05-11 07:32:39 ET
More on Dyne Therapeutics
- Dyne Therapeutics, Inc. (DYN) Presents at TD Cowen 46th Annual Health Care Conference Prepared Remarks Transcript
- Dyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case
- Dyne Therapeutics GAAP EPS of -$0.76 beats by $0.02
- Seeking Alpha’s Quant Rating on Dyne Therapeutics
- Historical earnings data for Dyne Therapeutics
Read the full article on Seeking Alpha
For further details see:
Dyne Therapeutics GAAP EPS of -$0.73 beats by $0.04
Dyne Therapeutics Inc.
NASDAQ: DYN
DYN Trading
-4.49% G/L:
$17.67 Last:
380,202 Volume:
$18.09 Open:
DYN Latest News
June 03, 2026 07:30:00 am
Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)
May 26, 2026 07:30:00 am
Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
May 25, 2026 06:56:40 pm
Dyne Spikes as Phase 3 Duchenne Trial Launch Strengthens Path Toward Potential 2027 Approval
DYN Stock Data
$2,792,339,585
138,744,373
0.04%
61
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
